Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252)

J. Chalmers; H. Arima; M. Woodward; G. Mancia; N. Poulter; Y. Hirakawa; S. Zoungas; A. Patel; B. Williams; S. Harrap

doi:10.1161/HYP.0000000000000030

Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252)

J. Chalmers, H. Arima, M. Woodward, G. Mancia, N. Poulter, Y. Hirakawa, S. Zoungas, A. Patel, B. Williams, S. Harrap

Bloomberg School of Public Health

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	e2
Journal	Hypertension
Volume	66
Issue number	1
DOIs	https://doi.org/10.1161/HYP.0000000000000030
State	Published - Jul 4 2015

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1161/HYP.0000000000000030

Cite this

Chalmers, J., Arima, H., Woodward, M., Mancia, G., Poulter, N., Hirakawa, Y., Zoungas, S., Patel, A., Williams, B., & Harrap, S. (2015). Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252). Hypertension, 66(1), e2. https://doi.org/10.1161/HYP.0000000000000030

Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252). / Chalmers, J.; Arima, H.; Woodward, M. et al.
In: Hypertension, Vol. 66, No. 1, 04.07.2015, p. e2.

Research output: Contribution to journal › Comment/debate › peer-review

Chalmers, J, Arima, H, Woodward, M, Mancia, G, Poulter, N, Hirakawa, Y, Zoungas, S, Patel, A, Williams, B & Harrap, S 2015, 'Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252)', Hypertension, vol. 66, no. 1, pp. e2. https://doi.org/10.1161/HYP.0000000000000030

Chalmers J, Arima H, Woodward M, Mancia G, Poulter N, Hirakawa Y et al. Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252). Hypertension. 2015 Jul 4;66(1):e2. doi: 10.1161/HYP.0000000000000030

Chalmers, J. ; Arima, H. ; Woodward, M. et al. / Erratum : Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252). In: Hypertension. 2015 ; Vol. 66, No. 1. pp. e2.

@article{254028dae1c24f969133b2cc2de5ca35,

title = "Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252)",

author = "J. Chalmers and H. Arima and M. Woodward and G. Mancia and N. Poulter and Y. Hirakawa and S. Zoungas and A. Patel and B. Williams and S. Harrap",

note = "Funding Information: This work was supported in part by Veterans Administration Merit Review Award; NO-1 AR-62224, RO1-AI-46990, and RO1-AI-42990 from National Institutes of Health. The production of transgenic mice at University of Alabama at Birmingham was supported by National Cancer Institute grant CA13148, to the University of Alabama at Birmingham Comprehensive Cancer Center. Hui-Chen Hsu is a recipient of a Center for Aging grant from the University of Alabama at Birmingham. Huang-Ge Zhang is a recipient of Arthritis Foundation Investigator Award. Tong Zhou is a recipient of Arthritis Foundation Biomedical Science Award.",

year = "2015",

month = jul,

day = "4",

doi = "10.1161/HYP.0000000000000030",

language = "English (US)",

volume = "66",

pages = "e2",

journal = "Hypertension",

issn = "0194-911X",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Erratum

T2 - Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252)

AU - Chalmers, J.

AU - Arima, H.

AU - Woodward, M.

AU - Mancia, G.

AU - Poulter, N.

AU - Hirakawa, Y.

AU - Zoungas, S.

AU - Patel, A.

AU - Williams, B.

AU - Harrap, S.

N1 - Funding Information: This work was supported in part by Veterans Administration Merit Review Award; NO-1 AR-62224, RO1-AI-46990, and RO1-AI-42990 from National Institutes of Health. The production of transgenic mice at University of Alabama at Birmingham was supported by National Cancer Institute grant CA13148, to the University of Alabama at Birmingham Comprehensive Cancer Center. Hui-Chen Hsu is a recipient of a Center for Aging grant from the University of Alabama at Birmingham. Huang-Ge Zhang is a recipient of Arthritis Foundation Investigator Award. Tong Zhou is a recipient of Arthritis Foundation Biomedical Science Award.

PY - 2015/7/4

Y1 - 2015/7/4

UR - http://www.scopus.com/inward/record.url?scp=84942763923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942763923&partnerID=8YFLogxK

U2 - 10.1161/HYP.0000000000000030

DO - 10.1161/HYP.0000000000000030

M3 - Comment/debate

C2 - 26063671

AN - SCOPUS:84942763923

SN - 0194-911X

VL - 66

SP - e2

JO - Hypertension

JF - Hypertension

IS - 1

ER -

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this